Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04100148 · ClinicalTrials.gov registry record · NA
SyncAV Post-Market Trial
A NA study of Congestive Heart Failure, sponsored by Abbott Medical Devices.
- Active
- Registry status
- NA
- Development phase
- 1,686
- Enrollment target
- 20
- Study locations
NCT04100148: Active NA study of Congestive Heart Failure, sponsored by Abbott Medical Devices.
NCT04100148 is a NA study of Congestive Heart Failure that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 1,686 participants, above the 297-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (468% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04100148, a NA study of Congestive Heart Failure, is active but no longer recruiting, sponsored by Abbott Medical Devices.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,686 participants
- Enrollment target
- 20
- Study locations
Study Summary
The SyncAV Post-Market Trial is a prospective, randomized, multi-center trial performed to determine if cardiac resynchronization therapy (CRT) devices programmed with SyncAV ON improve long-term CRT response compared to devices programmed with conventional CRT through evaluation of changes in left ventricular (LV) reverse remodeling.
Primary Outcome
Reduction of LVESV as a continuous variable from baseline to 12 months compared between subjects in the SyncAV and fixed AV delay arms.
Conditions Studied
Interventions
- DEVICE SyncAV programmed ON
- DEVICE Fixed AV delay
Study Locations (20)
California
- Comprehensive Cardiovascular - Bakersfield
- Cardiovascular Consultants Heart Center - Fresno
- USC University Hospital - Los Angeles
New Jersey
- Deborah Heart & Lung Center - Browns Mills
- Cardiovascular Associates of the Delaware Valley - Haddon Heights
- Lourdes Cardiology Services - Voorhees Township
Arizona
- Arizona Cardiovascular Research Center - Phoenix
- HonorHealth - Scottsdale
Florida
- Shands at the University of Florida - Gainesville
- Heart Rhythm Solutions - Hollywood
Georgia
- Piedmont Heart Institute - Atlanta
- Emory University Hospital - Atlanta
Alabama
- Heart Center Research, LLC. - Huntsville
Colorado
- Colorado Heart & Vascular, P.C. - Lakewood
Iowa
- Iowa Heart Center - West Des Moines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,686 participants |
| Start Date | 2019-10-03 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT04100148 still lists
NCT04100148 is an interventional study that assigns participants to a tested intervention. Its 1,686 participants enrollment target places it among the larger protocols in the corpus, above the 297-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (468% higher).
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which SyncAV programmed ON is the first listed.
NCT04100148 names 20 study sites across 13 states, led by California, New Jersey, Arizona.
Frequently Asked Questions
What is clinical trial NCT04100148 about?
NCT04100148 is a clinical study titled "SyncAV Post-Market Trial". The SyncAV Post-Market Trial is a prospective, randomized, multi-center trial performed to determine if cardiac resynchronization therapy (CRT) devices programmed with SyncAV ON improve long-term CRT response compared to devices programmed with conventional CRT through evaluation of changes in left ...
What is the current status of trial NCT04100148?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,686 participants. The study started on 2019-10-03. Estimated completion is 2026-06-30.
What conditions does trial NCT04100148 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT04100148?
The interventions under investigation include: SyncAV programmed ON (DEVICE), Fixed AV delay (DEVICE).
Who is sponsoring clinical trial NCT04100148?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04100148 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04100148's enrollment target sits among peer trials
1,686 3rd of 51 higher than 49 of 51 other Congestive Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring
COMPLETED · NA
-
Specialized Community Disease Management to Reduce Substance Use and Hospital Readmissions
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06376565 · 1,680 participants · NA
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
- NCT07284901 · 1,700 participants · Phase 3
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI